RESEARCH ARTICLE


Renal Clinical - Pathological Manifestations in Bullous Pemphigoid



Ke-Zhong Zhao*, Zhang Lian, Jian-Feng Liu, Yong-Hong Cai, Rui-Hong Han, Zhang Yan, Jin-Lei Wang, Yin-Lin Wang , Zhao Jin
Jinghai Clinical College, Tianjin Medical University, Tianjin, P.R. China


Article Metrics

CrossRef Citations:
0
Total Statistics:

Full-Text HTML Views: 3716
Abstract HTML Views: 1663
PDF Downloads: 727
ePub Downloads: 521
Total Views/Downloads: 6627
Unique Statistics:

Full-Text HTML Views: 1391
Abstract HTML Views: 905
PDF Downloads: 435
ePub Downloads: 331
Total Views/Downloads: 3062



Creative Commons License
© Zhao et al.; Licensee Bentham Open.

open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

* Address correspondence to this author at the Department of Nephrology, Jinghai Clinical College, Tianjin Medical University, Tianjin, P.R. China; Tel: +86-22-68924230; Fax: +86-22-28942928; E-mail: Kzz2568@126.com


Abstract

A 61-year old man was admitted with a 2-month history of skin rash, and proteinuria and intermittent hemoptysis for 2 weeks. The patient had developed circular erythema and blisters all over the body with scab formation. Edema of the legs and eyelids appeared 2 weeks prior to admission. Kidney biopsy showed membranous nephropathy (phase II) with focal segmental mesangial proliferation and deposits of IgG along the GBM. Skin biopsy demonstrated IgG deposits in the epidermal basement membrane zone. The simultaneous development of a rare renal and skin autoimmune disorder, resulting from non-cross-reactive autoantibodies, suggests that a common triggering event could be responsible for the autoimmune injury. This patient with bullous pemphigoid was treated with corticosteroids, which were tapered to an acceptable and effective maintenance dose following treatment with intravenous cyclophosphamide.

Keywords: Bullous pemphigoid, immunosupressant treatment, renal injury..